Helius Medical Technologies, Inc. announced the appointment of Jeffrey S. Mathiesen, CPA, to its Board of Directors, effective as of June 9, 2020. Upon his appointment, Mr. Mathiesen will serve as Chair of the Company’s Audit Committee. Mr. Mathiesen’s career experience includes executive and financial management positions with both public and private companies. He most recently worked for Teewinot Life Sciences Corporation from March 2019 to December 2019, where he served as Chief Financial Officer and later Advisor to the CEO. Mr. Mathiesen previously served as Chief Financial Officer of Gemphire Therapeutics Inc. from 2015 to 2018. Prior to joining Gemphire Therapeutics, Mr. Mathiesen served as Chief Financial Officer of Sunshine Heart, Inc. from 2011 to 2015. Mr. Mathiesen began his career at Deloitte & Touche LLP in 1983.